摘要
目的:探讨脑出血患者血浆内皮素-1(ET-1)和降钙素基因相关肽(CGRP)变化以及尼莫地平治疗对血浆ET-1和CGRP的影响。方法:60例脑出血患者随机分为尼莫地平组与常规治疗组,在治疗前后进行血浆ET-1、CGRP水平测定。结果:尼莫地平组和常规治疗组治疗前血浆ET-1和CGRP均显著增高,治疗后明显下降,治疗后血浆ET-1和CGRP降低值尼莫地平组明显高于常规治疗组(P<0.01)。尼莫地平组与常规治疗组治疗前临床神经功能缺损评分及BI评分与血浆ET-1和CGRP水平呈显著性相关,治疗后也呈显著性相关。结论:脑出血患者血浆ET-1及CGRP水平显著升高,尼莫地平治疗后明显下降。尼莫地平治疗脑出血有确切疗效,可减轻患者神经功能缺损程度,提高患者生活质量。
Objective:To investigate the variety of endothelin-1(ET-1)and calcitonin gene-related peptide(CGRP)in patients with intracerebral hemorrhage and the effect of nimodipine on them.Methods:60 patients with intracerebral hemorrhage were randomly divided into nimodipine treat group and normal treat group.The ET-1 and CGRP level in blood plasma were observed before and after treatment.Results:Before treating the ET-1 and CGRP level in blood plasma were increased apparently while decreased apparently after treatin...
出处
《陕西医学杂志》
CAS
北大核心
2008年第12期1604-1607,共4页
Shaanxi Medical Journal
